Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Brain Tumor, Blood, Breast, Ovarian, Lung Cancer), By Technology (Cleavable, Non-cleavable Linker), And Segment Forecasts, 2019 – 2025
The global antibody drug conjugates market size was valued at USD 1.57 billion in 2017 and is projected to register a CAGR of 25.9% over the forecast period.
Along with extensive R & D activities, major developments in linker technology will lead the market. Antibody drug conjugates (ADCs) are an innovative class of drugs that consist of antibodies linked to cytotoxic drugs through chemical linkers. ADCs are designed to benefit from the high specificity of monoclonal antibodies for the selective delivery of potent cytotoxic compounds to antigen-expressing tumor cells. Conventional chemotherapy is intended to eradicate rapidly growing tumor cells. But it can also damage healthy proliferating cells, causing undesirable side effects. In contrast, ADCs are designed to increase treatment efficacy and reduce systemic toxicity.
Request Sample Copy of this Report
The Top Key Players included in this Market:
Hoffmann-La Roche Ltd; Seattle Genetics, Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Immunomedics; and ImmunoGen Inc..
The Antibody Drug Conjugates Market is segmented based on type, organization size, industry vertical, and geography. As per type, the market is segmented into customer retention, customer loyalty, and channel loyalty. The report can effectively help companies and decision makers in addressing these challenges strategically to gain the maximum benefits in the highly competitive Antibody Drug Conjugates market. Data pertaining to the recent product and technological developments observed in the market, complete with an analysis of the impact of these advancements on the market’s future development is included in the report.
Leading key players have been profiled to get a clear insight into the businesses on the basis of successful strategies of the top level companies. Along with this, it also offers competitive significance among the several traders by presenting the facts and figures of market shares.
This research highlighting the current scenario of the Antibody Drug Conjugates market and focuses on some significant issues faced by various stakeholders.
Geographically, this report is segmented into several key regions:
United States, North America, Europe, Asia-Pacific, South America, Middle East and Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody Drug Conjugates for each application, including
Get Reasonable Discount on this Premium Report @:
Table of Contents
Global Antibody Drug Conjugates Market Research Report
Chapter 1 Antibody Drug Conjugates Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Global Antibody Drug Conjugates Market Forecast
– The report provides a detailed analysis on current and future market trends to identify the investment opportunities
– Market forecasts till 2025, using estimated market values as the base numbers
– Key market trends across the business segments, Regions and Countries
– Key developments and strategies observed in the market
– Market Dynamics such as Drivers, Restraints, Opportunities and other trends
– In-depth company profiles of key players and upcoming prominent players
– Growth prospects among the emerging nations through 2025
– Market opportunities and recommendations for new investments
For More Information:
At HealthCare Intelligence Markets
Address: 90, State Office Center,
90, State Street Suite 700,
Albany, NY 12207
Phone: +1 (888) 616-2766